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Although HTLV-1 is primarily found in T cells in infected
individuals, ex vivo cultures of T cells are not readily
infected by cell-free HTLV-1. In contrast, cell-free
HTLV-1 efficiently infects cultures of primary dendritic
cells. Little is known about the productive route of infec-
tion of dendritic cells, or the stage at which infection of
T cells is blocked. Comparison of primary CD4+ T cells
and monocyte-derived dendritic cells (MDDC) exposed to
HTLV-1 revealed that, for both cell types, HTLV-1 virions
bound to and entered the cells. Entry was dependent on
interactions with HSPGs and neuropilin-1, molecules
known to be involved in HTLV-1 entry. The observation
that cell-free HTLV-1 can enter both types of cells but
only efficiently infect DCs suggests that the virus can enter
cells by both productive and non-productive pathways.
Dendritic cells use a type of constitutive, actin-dependent
endocytosis called macropinocytosis to capture antigens,
and several viruses use this route to infect host cells. In
T cells, macropinocytosis is not constitutive, but can be
induced. Studies with inhibitors revealed that HTLV-1
infection of MDDC is markedly decreased when the cells
are treated with an actin-depolymerizing agent (cytochala-
sin D) or a specific inhibitor of macropinocytosis (EIPA).
Strikingly, treatment of primary CD4+ T cells with a pep-
tide that induces macropinocytosis dramatically increases
infection following exposure to cell-free HTLV-1. These
results suggest that HTLV-1 can enter cells by both pro-
ductive and non-productive pathways, and that altering
the route of entry can alter the susceptibility of a given cell
type to HTLV-1 infection.
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